Not applicableStudy completedNCT03091764What this trial is testingEvaluation of a Patient-Reported Symptom Index for NMIBCWho this might be right forSuperficial Bladder Cancer University of Sydney 498
Testing effectiveness (Phase 2)Active Not RecruitingNCT06187506What this trial is testingDisitamab Vedotin Combined With BCG Therapy in HER2-expressing High-risk Non-muscle Invasive Bladder CancerWho this might be right forNon-muscle Invasive Bladder CancerHER-2 Protein Overexpression Fudan University 20
Large-scale testing (Phase 3)Looking for participantsNCT07480356What this trial is testingEfficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder CancerWho this might be right forBladder (Urothelial, Transitional Cell) CancerNon-Muscle Invasive Bladder CarcinomaNon-muscle Invasive Bladder Cancer With Carcinoma in Situ Protara Therapeutics 284
Not applicableStudy completedNCT06768346What this trial is testingHyperthermic Intra-Vesical ChemotherapyWho this might be right forBladder Cancer Queen Mary University of London 259
Large-scale testing (Phase 3)Active Not RecruitingNCT05714202What this trial is testingTAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC)Who this might be right forBladder Cancer Janssen Research & Development, LLC 1,135
Not applicableStudy completedNCT07642102What this trial is testingEvaluation of the Role of Early Second Look TURBT in Management of High Risk Non Muscle Invasive Bladder CancerWho this might be right forBladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)Transurethral Resection of Bladder Tumor Ain Shams University 70
Not applicableEnded earlyNCT04412070What this trial is testingAssessement of the Concordance of Genomic Alterations Between Urine and Tissue in High-Risk NMIBC PatientsWho this might be right forBladder Cancer Hopital Foch 20
Testing effectiveness (Phase 2)Study completedNCT00003759What this trial is testingAD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder CancerWho this might be right forBladder Cancer Anthra Pharmaceuticals
Not applicableStudy completedNCT06126796What this trial is testingUrine-based Molecular Testing vs Cystoscopy for Surveillance of Nonmuscle Invasive Bladder Cancer (NMIBC)Who this might be right forNon-muscle Invasive Bladder Cancer Mayo Clinic 107
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06829823What this trial is testingClinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder CancerWho this might be right forNon-muscle Invasive Bladder Cancer (NMIBC) ImmunityBio, Inc. 20
Early research (Phase 1)Looking for participantsNCT07483970What this trial is testingA Phase I/II Study of JL19001 Injection Alone or in Combination With BCG in Subjects With High Risk Non-Muscle Invasive Bladder Cancer.Who this might be right forHigh Risk Non-muscle Invasive Bladder Cancer Jecho Biopharmaceuticals Co., Ltd. 18
Not applicableUnknownNCT02716961What this trial is testingTransurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder CancerWho this might be right forBladder CancerGemcitabine and Cisplatin ChemotherapyEpirubicin Instillation+2 more The First Affiliated Hospital with Nanjing Medical University 208
Large-scale testing (Phase 3)Looking for participantsNCT07804056What this trial is testingInvestigate the Efficacy and Safety of Alpha1H as a Neoadjuvant Therapy in Participants With Low- to Intermediate-Risk/Low-Grade Papillary Non-Muscle Invasive Bladder CancerWho this might be right forUrinary Bladder NeoplasmsNon-muscle Invasive Bladder Cancer (NMIBC) Hamlet Pharma AB 194
Early research (Phase 1)Study completedNCT01498172What this trial is testingBCG Modulation of the recMAGE-A3 + AS15 ASCI Response in the Treatment of Non Muscle Invasive Bladder Cancer (NMIBC) PatientsWho this might be right forBladder Cancer Patrice Jichlinski 23
Testing effectiveness (Phase 2)Looking for participantsNCT03945162What this trial is testingIntravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") PatientsWho this might be right forNon-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG Theralase® Technologies Inc. 90
Testing effectiveness (Phase 2)Looking for participantsNCT06732531What this trial is testingSafety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder CancerWho this might be right forBladder CancerNon Muscle Invasive Zhuhai Beihai Biotech Co., Ltd 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07800507What this trial is testingTrop2-Targeted Near-Infrared Fluorescence Imaging-Guided Precise Resection of Non-Muscle Invasive Bladder CancerWho this might be right forNMIBC Yunnan Cancer Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07777848What this trial is testingEvaluate the Efficacy and Safety of RAG-01 as Monotherapy and in Combination With Chemotherapy in Patients With Non-muscle Invasive Bladder Cancer (NMIBC).Who this might be right forNon-muscle Invasive Bladder Cancer (NMIBC) Ractigen Therapeutics. 114
Early research (Phase 1)Study completedNCT05085990What this trial is testingSafety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1b)Who this might be right forNon-muscle Invasive Bladder Cancer Protara Therapeutics 10
Not applicableStudy completedNCT03715660What this trial is testingXpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation StudyWho this might be right forBladder Cancer Mansoura University 198